Screener
iRadimed IRMD Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $21,979 | $19,511 |
| Cost of revenue | 5,165 | 4,668 |
| Gross profit | 16,814 | 14,843 |
| Operating expenses: | ||
| General and administrative | 4,569 | 4,611 |
| Sales and marketing | 4,052 | 4,176 |
| Research and development | 956 | 624 |
| Total operating expenses | 9,577 | 9,411 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's total revenue?
- iRadimed (IRMD) reported total revenue of $21.98M in Q1 2026.
- How has iRadimed's total revenue changed year-over-year?
- iRadimed's total revenue increased by 12.6% year-over-year, from $19.51M to $21.98M.
- What is the long-term trend for iRadimed's total revenue?
- Over 4 years (2021 to 2025), iRadimed's total revenue has grown at a 19.0% compound annual growth rate (CAGR), from $41.81M to $83.81M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about iRadimed's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude